Industry-funded trials shown to be biased
Of the 26 papers that were examined to determine the impact of funding or author conflicts of interest on the trial conclusions, 23 papers were found to show positive outcome for the sponsor. Four of these papers were found to have been interpreted favourably towards the sponsor in the conclusion, independent of the results.
Citation: Clinical Pharmacist URI: 11012805
Recommended from Pharmaceutical Press
An innovative book which presents statistics in the context of clinical trials conducted during pharmaceutical drug development.£38.00Buy now